Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

Charles C. Wykoff, Michael J. Elman, Carl D. Regillo, Beiying Ding, Na Lu, Ivaylo Stoilov

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences